The second-most abundant flavonoid in this sub-fraction was tentatively identified as liquiritigenin, which has been shown to decrease viability in breast cancer MDAMB-231 and BT549 cell lines by increasing apoptosis and enhancing caspase-3 activity in these cells [94]. This evidence concerns the gene CASP3 and breast cancer.